ArticleFrontiers in microbiology2022
Epidemiological features and spatial-temporal clustering of visceral leishmaniasis in mainland China from 2019 to 2021.
Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 22 citations in OpenAlex.
- First record of Phlebotomus sergenti (Diptera: Psychodidae) in China and its potential epidemiological implications.PLoS neglected tropical diseases · 2026Article
- Clinical Characteristics and Management of Four Cases of Visceral Leishmaniasis-Associated Hemophagocytic Lymphohistiocytosis.The American journal of tropical medicine and hygiene · 2026Article
- Zoonotic leishmaniasis in China: Current status and challenges to elimination.PLoS neglected tropical diseases · 2026Review
- Diseases Caused by Parasites with Invertebrate Hosts in China: Burden and Trends of Leishmaniasis and Schistosomiasis.Pathogens (Basel, Switzerland) · 2026Article
- The genome of Phlebotomus chinensis, the primary vector of visceral leishmaniasis in China: insights from chromosome-level assembly and comparative analysis.Infectious diseases of poverty · 2026Article
- Epidemiological Transition and Spatial Expansion of Mountain-Type Zoonotic Visceral Leishmaniasis - China, 2010-2024.China CDC weekly · 2026Article
- Geospatial modelling for zoonotic disease hotspot identification within a One Health framework: a systematic review.One health outlook · 2026Article
- Regression Analysis of the Main Environmental Risk Factors for Mountainous Subtype of Zoonotic VL in China.Journal of tropical medicine · 2026Article
- Analysis of suitable areas forFrontiers in cellular and infection microbiology · 2026Article
- Epidemiological Characteristics and Trends of Zoonotic Diseases in China from 2015 to 2022.Tropical medicine and infectious disease · 2025Article
- Visceral leishmaniasis related secondary haemophagocytic syndrome: A case report.The Journal of international medical research · 2025Article
- Case Report: A Case of Visceral Leishmaniasis Misdiagnosed as Brucellosis.Infection and drug resistance · 2025Article
- Spatial-temporal pattern and drivers associated with measles resurgence from 2018 to 2023: a global perspective from 192 countries.BMJ public health · 2025Article
- Epidemiological Features and Spatial-Temporal Clustering of Visceral Leishmaniasis - China, 2011-2022.China CDC weekly · 2024Article
- Rapid and reliable detection of Leishmania antibodies in canine serum with double-antigen sandwich homogeneous chemical luminescence.Parasites & vectors · 2024Article
- Re-emergence and influencing factors of mountain-type zoonotic visceral leishmaniasis in the extension region of Loess Plateau, China.PLoS neglected tropical diseases · 2024Article
- Clinical and laboratory characterization of cutaneous leishmaniasis in Chinese migrant workers returned from Iraq.PLoS neglected tropical diseases · 2024Article
- Case Report: Visceral Leishmaniasis Falsely Diagnosed as Viral Hepatitis C Without Febrile Symptoms.Infection and drug resistance · 2024Article
- Establishment of an indicator framework for the transmission risk of the mountain-type zoonotic visceral leishmaniasis based on the Delphi-entropy weight method.Infectious diseases of poverty · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Visceral leishmaniasis (VL) is a serious vector-borne disease in central and western China. In recent years, the number of VL cases increased gradually, particularly the mountain-type zoonotic visceral leishmaniasis (MT-ZVL). This study clarified the epidemiological features and spatial-temporal clustering of VL in China between 2019 and 2021, identified the risk areas for VL transmission, and provided scientific evidence for the prevention and control of VL. Materials and methods: The information on VL cases in 2019-2021 was collected from the Infectious Disease Reporting Information Management System of the Chinese Center for Disease Control and Prevention. The epidemiological characteristics of VL cases were analyzed. The global Results: A total of 608 VL cases were reported from 2019 to 2021, with 158, 213, and 237 cases reported each year, respectively. Of the 608 cases, there were 10 cases of anthroponotic visceral leishmaniasis (AVL), 20 cases of desert-type zoonotic visceral leishmaniasis (DT-ZVL), and 578 cases of MT-ZVL. The age of VL cases was mainly distributed in the group of subjects aged ≥ 15 years. Peasants and infants were the dominant high-risk population. The incidence peak season of VL occurred between March and May. The cases were mainly distributed in Shanxi (299 cases), Shaanxi (118 cases), and Gansu (106 cases) Provinces, accounting for 86.02% (523/608) of the total reported cases in China. Spatial analysis revealed that clustering of infection is mainly located in eastern Shanxi Province and Shaanxi-Shanxi border areas, as well as southern Gansu and northern Sichuan Province. In addition, new reemergence hotspots in Shanxi, Henan, and Hebei Provinces have been detected since 2020. Spatio-temporal clustering analysis revealed an increase in the degree of infection aggregation in eastern Shanxi Province and Shaanxi-Shanxi border areas. Conclusion: The AVL and DT-ZVL were endemic at a lower level in western China, whereas MT-ZVL rebounded rapidly and showed a resurgence in historically endemic counties. The spatial-temporal clustering analysis displayed that the high-incidence areas of VL have shifted to central China, particularly in Shanxi and Shaanxi Provinces. Integrated mitigation strategies targeting high-risk populations are needed to control VL transmission in high-risk areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.